1. Home
  2. ENOV vs ORIC Comparison

ENOV vs ORIC Comparison

Compare ENOV & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$25.24

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$10.25

Market Cap

837.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENOV
ORIC
Founded
1995
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
837.3M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
ENOV
ORIC
Price
$25.24
$10.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
$47.38
$19.73
AVG Volume (30 Days)
648.1K
2.4M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
19.67
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.36
N/A
Revenue Next Year
$5.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.00
$4.52
52 Week High
$36.82
$14.93

Technical Indicators

Market Signals
Indicator
ENOV
ORIC
Relative Strength Index (RSI) 62.04 46.94
Support Level $21.37 $9.75
Resistance Level $26.41 $10.79
Average True Range (ATR) 0.97 1.03
MACD 0.33 0.04
Stochastic Oscillator 90.67 52.67

Price Performance

Historical Comparison
ENOV
ORIC

About ENOV Enovis Corporation

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: